Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02643550
Title Study of IPH2201 (Monalizumab) and Cetuximab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Innate Pharma
Indications

oral cavity cancer

hypopharynx cancer

laryngeal squamous cell carcinoma

head and neck squamous cell carcinoma

oropharynx cancer

nasopharynx carcinoma

Therapies

Cetuximab + Monalizumab

Age Groups: adult
Covered Countries USA | FRA


No variant requirements are available.